Roche had multiple competitors in InterMune acquisition

InterMune Inc. (NASDAQ:ITMN) revealed in an SEC filing that multiple other companies expressed interest in a deal before Roche (SIX:ROG; OTCQX:RHHBY) agreed to acquire InterMune for $74 per share, or $8.3 billion in cash. Only one other suitor issued a proposal.

On July 26, Roche originally bid $70 per share in cash, a 54% premium to InterMune's close of $45.50 on July 25. An undisclosed company discussed a $57 per share cash deal with InterMune on Aug. 1. InterMune rejected both offers. ...